Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current Assets
Cash	$ 162,184	$ 110,441
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of December 31, 2020 and 2019, respectively	87,153	83,251
Inventory	95,200	70,460
Prepaid expenses and other	59,003	138,531
Total Current Assets	403,540	402,683
Property, plant and equipment, net of accumulated depreciation of $177,457 and $749,316 as of December 31, 2020 and 2019, respectively	437,286	513,788
Intangible assets, net of accumulated amortization of $151,776 and $5,908 as of December 31, 2020 and 2019, respectively	5,601,762	1,265,092
Goodwill	1,148,105	71,866
ROU lease assets and deposits	435,855	293,125
Total Assets	8,026,548	2,546,554
Current Liabilities
Accounts payable and accrued expenses	1,891,749	836,465
Contract liabilities	89,425
Lease liability, current portion	150,251	201,523
Due to related party, current portion	300,600	493,457
Notes payable to related party, current portion		743,955
Government and vendor notes payable, current portion	411,427
Convertible notes payable, net of original issue discount and debt discount of $-0- and $777,668 as of December 31, 2020 and 2019, respectively	1,336,350	1,542,036
Contingent acquisition consideration, current portion	701,961	100,000
Derivative financial instruments		991,288
Total Current Liabilities	4,881,763	4,908,724
Long-Term Liabilities
Government and vendor notes payable, long term portion	722,508
Contingent acquisition consideration, long term portion	798,479	400,000
Lease liability, long term portion	273,790	80,510
Total Liabilities	6,676,540	5,389,234
Shareholders’ Equity (Deficit)
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 187,967,881 and 109,894,490 shares issued and outstanding as of December 31, 2020 and 2019, respectively Series B convertible preferred stock, par value $0.001 per share, 20,000,000	18,797	10,990
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and -0- shares issued and outstanding as of December 31, 2020 and 2019, respectively	2,750
Common stock issuable, $0.0001 par value; 2,150,020 and 1,047,904 shares as of December 31, 2020 and 2019, respectively	262,273	159,538
Additional paid-in capital	22,851,098	13,016,446
Accumulated deficit	(21,784,910)	(16,029,654)
Total Shareholders’ Equity (Deficit)	1,350,008	(2,842,680)
Total Liabilities and Shareholders’ Equity (Deficit)	$ 8,026,548	$ 2,546,554